|
Pathophysiology
Citations 31-40 of 269 total displayed.
|
Past content
(since Jun 1999):
|
- Brief Reviews
Modulation of the Endocannabinoid System in Cardiovascular Disease: Therapeutic Potential and Limitations
- Pál Pacher, Partha Mukhopadhyay, Rajesh Mohanraj, Grzegorz Godlewski, Sándor Bátkai, and George Kunos
Hypertension 2008;52:601-607; published online before print as doi:10.1161/HYPERTENSIONAHA.105.063651
[Full text]
- Scientific Contributions
Association Between Different Measures of Blood Pressure and Coronary Artery Calcium in Postmenopausal Women
- Matthew A. Allison, JoAnn E. Manson, Robert D. Langer, Aaron Aragaki, Sylvia Smoller, Cora E. Lewis, Asha Thomas, William Lawson, Barbara B. Cochrane, Judith Hsia, Julie R. Hunt, and Jennifer Robinson
Hypertension published September 15, 2008, doi:10.1161/HYPERTENSIONAHA.108.118315
[Abstract]
- Scientific Contributions
Simultaneous Measurement of Beat-to-Beat Carotid Diameter and Pressure Changes to Assess Arterial Mechanical Properties
- Cristina Giannattasio, Paolo Salvi, Filippo Valbusa, Anna Kearney-Schwartz, Anna Capra, Maria Amigoni, Monica Failla, Lucia Boffi, Fabiana Madotto, Athanasios Benetos, and Giuseppe Mancia
Hypertension published September 15, 2008, doi:10.1161/HYPERTENSIONAHA.108.116509
[Abstract]
- Brief Reviews
Modulation of the Endocannabinoid System in Cardiovascular Disease. Therapeutic Potential and Limitations
- Pál Pacher, Partha Mukhopadhyay, Rajesh Mohanraj, Grzegorz Godlewski, Sándor Bátkai, and George Kunos
Hypertension published September 8, 2008, doi:10.1161/HYPERTENSIONAHA.105.063651
[Abstract]
- Letters to the Editor
Endothelial Dysfunction, Isoprostanes, and Copper Deficiency
- Leslie M. Klevay
Hypertension 2008;52:e27; published online before print as doi:10.1161/HYPERTENSIONAHA.108.115758
[Full text]
- Editorial Commentaries
Endothelin Receptor Antagonism: What Does the Future Hold?
- Domenic A. Sica
Hypertension 2008;52:460-461; published online before print as doi:10.1161/HYPERTENSIONAHA.108.117226
[Full text]
- Editorial Commentaries
Aliskiren Improves Nitric Oxide Bioavailability and Limits Atherosclerosis
- Subodh Verma and Milan K. Gupta
Hypertension 2008;52:467-469; published online before print as doi:10.1161/HYPERTENSIONAHA.108.114488
[Full text]
- Editorial Commentary
Endothelin Receptor Antagonism. What Does the Future Hold?
- Domenic A. Sica
Hypertension published August 11, 2008, doi:10.1161/HYPERTENSIONAHA.108.117226
[Abstract]
- Letters to the Editor
Combination Therapy for Treatment or Prevention of Atherosclerosis
- Kwang Kon Koh and Michael J. Quon
Hypertension 2008;52:e18; published online before print as doi:10.1161/HYPERTENSIONAHA.108.115840
[Full text]
- Letters to the Editor
Endothelial Dysfunction, Isoprostanes, and Copper Deficiency
- Leslie M. Klevay
Hypertension published July 28, 2008, doi:10.1161/HYPERTENSIONAHA.108.115758
[Abstract]
|
|
